STOCK TITAN

VistaGen Therapeutics to Participate in Baird’s 2021 Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

VistaGen Therapeutics (NASDAQ: VTGN) announced participation in Baird’s 2021 Global Healthcare Conference on September 14, 2021, at 12:10 p.m. PT. CEO Shawn Singh will lead a fireside chat and engage in one-on-one meetings during the two-day event. A live webcast of the presentation will be available on the Investors section of VistaGen's website. The company focuses on developing innovative medicines for anxiety, depression, and other CNS disorders, with three drug candidates currently showing promise in clinical studies.

Positive
  • None.
Negative
  • None.

SOUTH SAN FRANCISCO, Calif., Sept. 08, 2021 (GLOBE NEWSWIRE) -- VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company committed to developing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression, and other central nervous system (“CNS”) disorders, today announced that management will participate in Baird’s 2021 Global Healthcare Conference, including a fireside chat with Shawn Singh, Chief Executive Officer, on Tuesday, September 14 at 12:10 p.m. Pacific Time and one-on-one meetings throughout the two-day conference.

A live webcast of VistaGen’s presentation will be accessible through the News/Events page of the Investors section of the Company’s website at www.VistaGen.com.

About VistaGen
VistaGen Therapeutics is a biopharmaceutical company committed to developing and commercializing innovative medicines with the potential to go beyond the current standard of care for anxiety, depression, and other CNS disorders. Each of VistaGen's three drug candidates has a differentiated potential mechanism of action, has been well-tolerated in all clinical studies to date, and has therapeutic potential in multiple CNS markets. For more information, please visit www.VistaGen.com and connect with VistaGen on TwitterLinkedIn, and Facebook.

VistaGen Company Contacts

Media:
Mark McPartland
Phone: (650) 577-3606
Email: IR@vistagen.com

Investors:
Mark Flather
Phone: (650) 577-3617
Email: IR@vistagen.com 

 


FAQ

What event is VistaGen participating in on September 14, 2021?

VistaGen Therapeutics will participate in Baird’s 2021 Global Healthcare Conference.

Who is representing VistaGen at the Baird Healthcare Conference?

CEO Shawn Singh will represent VistaGen at the conference.

What time is VistaGen's presentation at the conference?

VistaGen's presentation is scheduled for 12:10 p.m. Pacific Time.

Where can I watch VistaGen's presentation live?

The presentation will be available via webcast on the Investors section of VistaGen's website.

What does VistaGen Therapeutics specialize in?

VistaGen Therapeutics specializes in developing innovative medicines for anxiety, depression, and CNS disorders.

Vistagen Therapeutics, Inc.

NASDAQ:VTGN

VTGN Rankings

VTGN Latest News

VTGN Stock Data

62.65M
27.77M
0.25%
53.63%
1.54%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
SOUTH SAN FRANCISCO